Statements (51)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
hormone
androgen |
| gptkbp:CASNumber |
58-22-0
|
| gptkbp:chemicalFormula |
C19H28O2
|
| gptkbp:discoveredBy |
gptkb:Ernst_Laqueur
|
| gptkbp:discoveredIn |
1935
|
| gptkbp:excretion |
kidneys
|
| gptkbp:foundIn |
humans
mammals vertebrates |
| gptkbp:function |
regulation of mood
development of male reproductive tissues growth of body hair increase in muscle and bone mass promotion of secondary sexual characteristics regulation of energy regulation of libido |
| https://www.w3.org/2000/01/rdf-schema#label |
Testosterone
|
| gptkbp:IUPACName |
17β-hydroxyandrost-4-en-3-one
|
| gptkbp:KEGGID |
D00068
|
| gptkbp:meltingPoint |
155 °C
|
| gptkbp:MeSH_ID |
D014 Testosterone
|
| gptkbp:metabolism |
liver
|
| gptkbp:molecularWeight |
288.42 g/mol
|
| gptkbp:predecessor |
gptkb:estradiol
gptkb:dihydrotestosterone |
| gptkbp:producedBy |
adrenal glands
ovaries testes |
| gptkbp:PubChem_CID |
gptkb:CHEMBL691
gptkb:DB00624 6013 |
| gptkbp:regulates |
gptkb:luteinizing_hormone
gonadotropin-releasing hormone |
| gptkbp:routeOfAdministration |
oral
transdermal intramuscular injection subcutaneous injection |
| gptkbp:sideEffect |
acne
mood changes voice changes increased hair growth increased risk of cardiovascular disease |
| gptkbp:UNII |
3XMK78S47O
|
| gptkbp:usedFor |
gptkb:drug
hypogonadism delayed puberty certain types of breast cancer |
| gptkbp:bfsParent |
gptkb:Schedule_III
gptkb:Cholesterol |
| gptkbp:bfsLayer |
6
|